Pediatric BMT Program
Grand Hall AB (Manchester Grand Hyatt)
Chair:
Christopher C. Dvorak, MD
Disclosures:
C. C. Dvorak,
Nothing To Disclose
Autologous Transplant/Gene Therapy for Adenosine Deaminase-Deficient Severe Combined Immune Deficiency
Donald B. Kohn, University of California, Los Angeles;
Kit L Shaw, University of California, Los Angeles;
Robert Sokolic, MD, National Human Genome Research Institute;
Denise A Carbonaro, University of California, Los Angeles;
Alejandar Davila, University of California, Los Angeles;
Provaboti Barman, University of California, Los Angeles;
Elizabeth Garabedian, National Genome Research Institute, NIH;
Christopher Silvin, National Genome Research Institute, NIH;
Satiro De Oliveira, MD, David Geffen School of Medicine at UCLA;
Ami J Shah, MD, University of California, Los Angeles;
Theodore B Moore, MD, David Geffen School of Medicine at UCLA;
Michael Hershfield, Duke University School of Medicine;
Adrian Thrasher, University College LOndon;
H. Robert Gaspar, University College London;
Fabio Candotti, NHGRI, NIH
Neuroblastoma and Ewing's Sarcoma Associated with ROR1 Expression Can be Effectively Targeted with NK Cells Modified to Express an Anti ROR1 Chimeric Antigen Receptor
Mona Elmacken, MD, New York Medical College;
Aradhana Awasthi, PhD, New York Medical College;
Janet Ayello, MS, MT(ASCP), New York Medical College;
Carmella van de Ven, MS, New York Medical College;
Wen Luo, PhD, New York Medical College;
Yanling Liao, PhD, New York Medical College;
Stanley Riddell, MD, Fred Hutchinson Cancer Research Center;
Mitchell S. Cairo, MD, New York Medical College
Studying the Optimal Intravenous Busulfan Exposure in Pediatric Allogeneic Hematopoietic Cell Transplantation (alloHCT) to Improve Clinical Outcomes: A Multicenter Study
Arief Lalmohamed, PharmD, PhD, University Medical Center Utrecht;
Imke Bartelink, PharmD, PhD, University of San Francisco;
Liesbeth van Reij, PharmD, University Medical Center Utrecht;
Christopher C. Dvorak, MD, University of San Francisco;
Rada Savic, PhD, University of San Francisco;
Juliëtte Zwaveling, PharmD, PhD, Leiden University Medical Center;
Robbert Bredius, MD, PhD, Leiden University Medical Center;
Antoine Egberts, PharmD, PhD, University Medical Center Utrecht;
Marc Bierings, MD, PhD, University Medical Center Utrecht;
Morris Kletzel, MD, FAAP, MBA, Northwestern University Feinberg School of Medicine;
Peter John Shaw, MD, Children's Hospital at Westmead;
Christa Nath, PhD, Children’s Hospital at Westmead;
Georg Hempel, PhD, Universitätsklinikum at Münster;
Marc Ansari, MD, Hôpital des enfants (HUG) Genève;
Maja Krajinovic, MD, PhD, Hôpital des enfants (HUG) Genève;
Tayfun Gungor, MD, University Childrens Hospital Zurich;
Robert F. Wynn, MD, Royal Manchester Children's Hospital;
Paul Veys, MBBS, Great Ormond Street Hospital for Children;
Geoff Cuvelier, MD, CancerCare Manitoba;
Robert Chiesa, MD, PhD, Great Ormond Street Hospital for Children;
Mary Slatter, MD, Great North Children's Hospital;
Janel Long-Boyle, PharmD, PhD, University of San Francisco;
Jaap-Jan Boelens, MD, PhD, University Medical Center Utrecht
Peripheral Blood Expansion of CD38 Bright CD8+ Effector Memory T- Cells Predicts Acute Graft Versus Host Disease with a Diagnostic Accuracy of 87%
Pooja Khandelwal, MD, Cincinnati Children's Hospital Medical Center;
Adam Lane, PhD, Cincinnati Children's Hospital Medical Center;
Erika Owsley, Cincinnati Children's Hospital Medical Center;
Vijaya Chaturvedi, Cincinnati Children's Hospital Medical Center;
Michael B Jordan, MD, Cincinnati Children's Hospital Medical Center;
Stella M. Davies, MBBS, PhD, MRCP, Cincinnati Children's Hospital Medical Center;
Daniel J Marmer, MS MT(ASCP), Cincinnati Children's Hospital Medical Center;
Alexandra Filipovich, MD, Cincinnati Children's Hospital Medical Center;
Rebecca A. Marsh, MD, Cincinnati Children's Hospital Medical Center
Genetic Modifier of the Gut Microbiome, GVHD and Bacterial Translocation Following HSCT
Ahmad Rayes, MD, Cincinnati Children's Hospital Medical Center;
Ardythe L Morrow, PhD, Cincinnati Children’s Hospital Medical Center;
Doyle V Ward, PhD, Broad Institute;
Leslie R Payton, BS, Cincinnati Children's Hospital Medical Center;
Kelly E Lake, BS, Cincinnati Children's Hospital Medical Center;
Adam Lane, PhD, Cincinnati Children's Hospital Medical Center;
Stella M. Davies, MBBS, PhD, MRCP, Cincinnati Children's Hospital Medical Center
The Genetic Fingerprint of Susceptibility to Transplant Associated Thrombotic Microangiopathy
Sonata Jodele, MD, Cincinnati Children's Hospital Medical Center;
Benjamin Laskin, MD, MS, Cincinnati Children's Hospital Medical Center, Cincinnati;
Kejian Zhang, MD, MBA, Cincinnati Childrens Hospital Medical Center;
Fanggeng Zou, MD, Cincinnati Childrens Hospital Medical Center;
Christopher E Dandoy, MD, MSc, Cincinnati Children's Hospital Medical Center;
Kasiani C. Myers, MD, Cincinnati Children's Hospital Medical Center;
Javier El-Bietar, MD, Cincinnati Children's Hospital Medical Center;
Gregory Wallace, DO, Cincinnati Children's Hospital Medical Center;
Michael S. Grimley, MD, Cincinnati Children's Hospital Medical Center;
Jack Bleesing, MD, PhD, Cincinnati Children's Hospital Medical Center;
Jens Goebel, MD, Cincinnati Children's Hospital Medical Center;
Diane Kissell, Cincinnati Children's Hospital Medical Center;
Shannon Nortman, Cincinnati Children's Hospital Medical Center;
Adam Lane, PhD, Cincinnati Children's Hospital Medical Center;
Stella M. Davies, MBBS, PhD, MRCP, Cincinnati Children's Hospital Medical Center
![[Visit Client Website]](images/banner.gif)